Fungal Infections Caused by <i>Kazachstania</i> spp., Strasbourg, France, 2007–2020
Charlotte Kaeuffer(Université de Strasbourg), François Danion(Hôpitaux Universitaires de Strasbourg), Yves-Jean Zhu(Université de Strasbourg), Francis Schneider(Hôpitaux Universitaires de Strasbourg), Raoul Herbrecht(Institut de Cancérologie Strasbourg), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), Yvon Ruch(Hôpitaux Universitaires de Strasbourg), Manon De Cian(Amgen (United States)), Mathieu Baldacini(Amgen (United States)), Julie Denis(Hôpitaux Universitaires de Strasbourg), Tiffany Ruge(Amgen (United States)), Marcela Sabou(Amgen (United States)), Guillaume Philouze(Amgen (United States)), Nicolas Lefèbvre(Hôpital Civil, Strasbourg), Valérie Letscher‐Bru, Philippe Bachellier(Hôpitaux Universitaires de Strasbourg)
Cited by 22
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k